Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Geminitherapeutics
What Does Geminitherapeutics Do?
Geminitherapeutics, Inc. was a clinical-stage precision medicine company dedicated to developing innovative treatments for genetically-defined age-related macular degeneration (AMD) and associated ocular conditions. Their lead drug candidate was GEM103, a recombinant human complement factor H (CFH). In August 2022, Geminitherapeutics was acquired by Disc Medicine, Inc. (NASDAQ: IRON), and the combined company now operates under the Disc Medicine name, focusing on hematologic disorders.
Where Is Geminitherapeutics's Headquarters?
HQ Function
Served as the primary center for research and development, clinical trial management, and corporate operations for Geminitherapeutics prior to its acquisition.
Notable Features:
Located within a modern bio-pharma park, the facility likely featured standard laboratory and office spaces tailored for a clinical-stage biotechnology company.
Work Culture:
Prior to acquisition, the work culture was likely characterized by a fast-paced, innovative, and scientifically-driven environment, typical of clinical-stage biotech companies focused on achieving research milestones and drug development.
HQ Significance:
This location was central to Geminitherapeutics' efforts in advancing its lead candidate GEM103 through clinical trials and managing its precision medicine programs.
Values Reflected in HQ: The choice of Cambridge as its headquarters reflected a commitment to innovation, access to a rich talent pool, and proximity to a vibrant biotech ecosystem.
Location:
Prior to its acquisition, Geminitherapeutics was primarily focused on its operations and clinical development programs within the United States. While its therapeutic candidates were intended for global patient populations, its physical corporate and research presence was centralized in the U.S.
Street Address:
125 Cambridgepark Drive, Suite 301
City:
Cambridge
State/Province:
MA
Country:
USA
Where Else Does Geminitherapeutics Operate Around the World?
No additional office locations available.
Buying Intent Signals for Geminitherapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading Geminitherapeutics? Meet the Executive Team
As of April 2025, Geminitherapeutics' leadership includes:
Who's Investing in Geminitherapeutics?
Geminitherapeutics has been backed by several prominent investors over the years, including:
What Leadership Changes Has Geminitherapeutics Seen Recently?
In its final year of independent operation leading up to the August 2022 merger with Disc Medicine, Geminitherapeutics saw the departure of its Chief Development Officer. The merger itself resulted in a complete transition of the executive leadership team as the combined company came under Disc Medicine's leadership.
Departures
What Technology (Tech Stack) Is Used byGeminitherapeutics?
Discover the tools Geminitherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Geminitherapeutics Email Formats and Examples
Prior to its acquisition by Disc Medicine, Geminitherapeutics likely used common corporate email formats such as [first_initial][last]@geminitherapeutics.com or [first].[last]@geminitherapeutics.com. As the company and its domain are no longer independently operational, these email formats are historical and emails to such addresses would not be delivered.
[first_initial][last]@geminitherapeutics.com or [first].[last]@geminitherapeutics.com
Format
jdoe@geminitherapeutics.com or jane.doe@geminitherapeutics.com
Example
0%
Success rate
What's the Latest News About Geminitherapeutics?
Disc Medicine / GlobeNewswire • August 16, 2022
Disc Medicine and Geminitherapeutics Complete Merger
Disc Medicine and Geminitherapeutics announced the completion of their previously announced merger. The combined, publicly traded company will operate under the name Disc Medicine, Inc. and focus on advancing Disc's pipeline of hematology programs. Geminitherapeutics stock ceased trading....more
Geminitherapeutics / GlobeNewswire • May 24, 2022
Geminitherapeutics and Disc Medicine Announce Merger Agreement
Geminitherapeutics and Disc Medicine entered into a definitive merger agreement to combine in an all-stock transaction. The merged company would focus on Disc's clinical-stage pipeline of novel treatments for serious hematologic diseases, with Disc Medicine leadership helming the combined entity....more
Geminitherapeutics / Business Wire • February 10, 2021
Geminitherapeutics Announces Closing of Business Combination with FS Development Corp. and PIPE Financing
Geminitherapeutics announced the closing of its business combination with FS Development Corp. (FSDC), a special purpose acquisition company (SPAC). The combined company's common stock began trading on the Nasdaq Global Market under the ticker symbol 'GMTX' on February 11, 2021....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Geminitherapeutics, are just a search away.